已收盘 07-01 16:00:00 美东时间
0.000
0.00%
Inozyme Pharma has postponed its 2025 Annual Meeting due to the pending acquisition by BioMarin Pharmaceutical Inc. If the acquisition is completed, the Annual Meeting will not occur. If not, the Board will decide on further steps to reschedule the meeting.
06-20 21:00
Stifel analyst Dae Gon Ha initiates coverage on Inozyme Pharma (NASDAQ:INZY) with a Buy rating and announces Price Target of $16.
2024-09-12 18:46
Shares of Nikola Corporation (NASDAQ:NKLA) fell sharply in Monday's session after the company announced it entered into a securities purchase agreement and filed for a mixed shelf offering. Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in today’s mid-day session. G...
2024-08-20 01:37